HighTower Advisors’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-482
Closed -$5.42K 3973
2024
Q4
$5.42K Hold
482
﹤0.01% 3625
2024
Q3
$9K Hold
482
﹤0.01% 3559
2024
Q2
$11K Hold
482
﹤0.01% 3441
2024
Q1
$25K Hold
482
﹤0.01% 3333
2023
Q4
$34K Hold
482
﹤0.01% 3352
2023
Q3
$35K Hold
482
﹤0.01% 3267
2023
Q2
$72K Hold
482
﹤0.01% 3129
2023
Q1
$26K Sell
482
-20
-4% -$1.2K ﹤0.01% 3122
2022
Q4
$46K Sell
502
-2
-0.4% -$433 ﹤0.01% 3045
2022
Q3
$116K Hold
504
﹤0.01% 2736
2022
Q2
$94K Sell
504
-20
-4% -$5.57K ﹤0.01% 2801
2022
Q1
$205K Hold
524
﹤0.01% 2831
2021
Q4
$185K Buy
+524
New +$250K ﹤0.01% 2802

Other funds holding PIII

HighTower Advisors's PIII Position: Q1 2025 in Review

HighTower Advisors sold out of P3 Health Partners (PIII) in Q1 2025, closing a stake of 482 shares — an estimated $5.42K sold.

HighTower Advisors first reported a position in PIII in Q4 2021 and held it in 13 quarters. The position peaked at $205K in Q1 2022. 33 funds tracked by Wall St. Rank hold PIII as of Q1 2025.

  • HighTower Advisors reported no remaining P3 Health Partners position as of Q1 2025 after selling out during the quarter.
  • HighTower Advisors sold 482 P3 Health Partners shares in Q1 2025, an estimated $5.42K.
  • HighTower Advisors first reported a position in P3 Health Partners in Q4 2021 and held it in 13 quarters.
  • HighTower Advisors's P3 Health Partners position peaked at $205K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held P3 Health Partners as of Q1 2025.

Based on HighTower Advisors's 13F filing for Q1 2025, filed 13 May 2025.